PT  - JOURNAL ARTICLE
AU  - Berthet, Pierre
AU  - Haatveit, Beathe C.
AU  - Kjelkenes, Rikka
AU  - Worker, Amanda
AU  - Kia, Seyed Mostafa
AU  - Wolfers, Thomas
AU  - Rutherford, Saige
AU  - Alnaes, Dag
AU  - Dinga, Richard
AU  - Pedersen, Mads L.
AU  - Dahl, Andreas
AU  - Fernandez-Cabello, Sara
AU  - Dazzan, Paola
AU  - Agartz, Ingrid
AU  - Nesvåg, Ragnar
AU  - Ueland, Torill
AU  - Andreassen, Ole A.
AU  - Simonsen, Carmen
AU  - Westlye, Lars T.
AU  - Melle, Ingrid
AU  - Marquand, Andre
TI  - A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis using Normative Models
AID  - 10.1101/2024.04.19.24306008
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.19.24306008
4099  - http://medrxiv.org/content/early/2024/05/27/2024.04.19.24306008.short
4100  - http://medrxiv.org/content/early/2024/05/27/2024.04.19.24306008.full
AB  - Background Clinical forecasting models have potential to optimize treatment and improve outcomes in psychosis, but predicting long-term outcomes is challenging and long-term follow up data are scarce. In this 10-year longitudinal study we aimed to characterize the temporal evolution of cortical correlates of psychosis and their associations with symptoms.Design Structural MRI from people with first-episode psychosis and controls (n=79 and 218) were obtained at enrollment, after 12 months (n=67 and 197), and 10 years (n=23 and 77), within the Thematically Organized Psychosis (TOP) study. Normative models for cortical thickness estimated on public MRI datasets (n=42983) were applied to TOP data to obtain deviation scores for each region and timepoint. Positive And Negative Syndrome Scale (PANSS) scores were acquired at each timepoint along with registry data. Linear mixed effects (LME) models assessed effects of diagnosis, time and their interactions on cortical deviations plus associations with symptoms.Results LMEs revealed conditional main effects of diagnosis and time x diagnosis interactions in a distributed cortical network, where negative deviations in patients attenuate over time. In patients, symptoms also attenuate over time. LMEs revealed effects of anterior cingulate on PANSS total, and insular and orbitofrontal regions on PANSS negative scores.Conclusions This long-term longitudinal study revealed a distributed pattern of cortical differences which attenuated over time together with a reduction in symptoms. These findings are not in line with a simple neurodegenerative account of schizophrenia, and deviations from normative models offer a promising avenue to develop biomarkers to track clinical trajectories over time.Competing Interest StatementOAA Consultant to cortechs.ai, speaker honorarium from Sunvion, Janssen, Lundbeck. Regional PI for clinical trials funded by BI, MAPS, Janssen. Other authors do not report any conflict of interests. Funding StatementThis study was supported by grant number BRAINCHART, 215698/Z/19/Z from the Wellcome Trust Innovator Award, the Research Council of Norway (#223273, #287714), the KG Jebsen Stiftelsen, the European Research Council under the European Union Horizon 2020 Research and Innovation program (ERC StG, grant 802998), and South-Eastern Norway Regional Health Authority (grants #2006233, #2006258, #2009037, #2011085, #2011096, #2012100, #2014102, #2015088, #2018093, #2019107, #2020086).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is approved by the Regional Ethics Committee of South-Eastern Norway. All participants gave informed consent by signing a written consent form. Consent could be withdrawn at any time.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWhile the authors are open to collaborations using these data, data used in the present study can not be shared due to some participants not providing consent for data sharing.